These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 37720350)

  • 1. Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer.
    Hoskin AJ; Holt AK; Legge DN; Collard TJ; Williams AC; Vincent EE
    Explor Target Antitumor Ther; 2023; 4(4):600-615. PubMed ID: 37720350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition.
    Holt AK; Najumudeen AK; Collard TJ; Li H; Millett LM; Hoskin AJ; Legge DN; Mortensson EMH; Flanagan DJ; Jones N; Kollareddy M; Timms P; Hitchings MD; Cronin J; Sansom OJ; Williams AC; Vincent EE
    Cancer Metab; 2023 Oct; 11(1):18. PubMed ID: 37858256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Reprogramming of Cancer by Chemicals that Target Glutaminase Isoenzymes.
    Matés JM; Campos-Sandoval JA; de Los Santos-Jiménez J; Segura JA; Alonso FJ; Márquez J
    Curr Med Chem; 2020; 27(32):5317-5339. PubMed ID: 31038055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutaminase isoenzymes in the metabolic therapy of cancer.
    Matés JM; Campos-Sandoval JA; Márquez J
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):158-164. PubMed ID: 30053497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
    Magaway C; Kim E; Jacinto E
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma.
    Emberley E; Pan A; Chen J; Dang R; Gross M; Huang T; Li W; MacKinnon A; Singh D; Sotirovska N; Steggerda SM; Wang T; Parlati F
    PLoS One; 2021; 16(11):e0259241. PubMed ID: 34731180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin Prevention of Colorectal Cancer: Focus on NF-κB Signalling and the Nucleolus.
    Chen J; Stark LA
    Biomedicines; 2017 Jul; 5(3):. PubMed ID: 28718829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
    PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of aspirin analogues that repress NF-κB signalling and demonstrate anti-proliferative activity towards colorectal cancer in vitro and in vivo.
    Claudius AK; Kankipati CS; Kilari RS; Hassan S; Guest K; Russell ST; Perry CJ; Stark LA; Nicholl ID
    Oncol Rep; 2014 Oct; 32(4):1670-80. PubMed ID: 25109257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging hypoxia, inflammation and estrogen receptors in thyroid cancer progression.
    Tafani M; De Santis E; Coppola L; Perrone GA; Carnevale I; Russo A; Pucci B; Carpi A; Bizzarri M; Russo MA
    Biomed Pharmacother; 2014 Feb; 68(1):1-5. PubMed ID: 24286852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
    Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
    Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells.
    Petővári G; Hujber Z; Krencz I; Dankó T; Nagy N; Tóth F; Raffay R; Mészáros K; Rajnai H; Vetlényi E; Takács-Vellai K; Jeney A; Sebestyén A
    Cancer Cell Int; 2018; 18():211. PubMed ID: 30574020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy.
    Abdel-Wahab AF; Mahmoud W; Al-Harizy RM
    Pharmacol Res; 2019 Dec; 150():104511. PubMed ID: 31678210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine Is Required for M1-like Polarization of Macrophages in Response to Mycobacterium tuberculosis Infection.
    Jiang Q; Qiu Y; Kurland IJ; Drlica K; Subbian S; Tyagi S; Shi L
    mBio; 2022 Aug; 13(4):e0127422. PubMed ID: 35762591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Reprogramming in Thyroid Carcinoma.
    Coelho RG; Fortunato RS; Carvalho DP
    Front Oncol; 2018; 8():82. PubMed ID: 29629339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates on the molecular mechanisms of aspirin in the prevention of colorectal cancer: Review.
    Belayneh YM; Amare GG; Meharie BG
    J Oncol Pharm Pract; 2021 Jun; 27(4):954-961. PubMed ID: 33427041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer.
    Schrör K
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):473-84. PubMed ID: 22122764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.